Yigal H. Ehrlich
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yigal H. Ehrlich has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
E Kornecki
4 shared publications- Anna Babinska
Division of Nephrology, Department of Medicine, State University of New York, Downstate Medical Center, Brooklyn, NY, 11203; Department of Cell Biology and Medicine, State University of New York, Downstate Medical Center, Brooklyn, NY, 11203
3 shared publications - T. Sobocki
Program in Neuroscience and Department of Chemistry, College of Staten Island, CUNY, 2800 Victory Blvd., 6S-326, Staten Island, NY 10314, USA
2 shared publications A J Norin
1 shared publication- Andrzej Wieraszko
Department of Biology and CSI/IBR Center for Developmental Neuroscience, The College of Staten Island/CUNY, 2800 Victory Boulevard, Staten Island, United States
1 shared publication C Weiss
1 shared publication
Latest Publications
- 15 April 2000
- Vol. 95 (8) , 2600-9
Cloning of the human platelet F11 receptor: a cell adhesion molecule member of the immunoglobulin superfamily involved in platelet aggregation.
This study demonstrates that the human platelet F11 receptor (F11R) functions as an adhesion molecule, and this finding is confirmed by the structure of the protein as revealed by molecular cloning. The F11R is a 32-/35-kd protein duplex that serves as the binding site through which a stimulatory monoclonal antibody causes platelet aggregation and granule secretion. A physiological role for the F11R protein was demonstrated by its phosphorylation after the stimulation of platelets by thrombin and collagen. A pathophysiological role for the F11R was revealed by demonstrating the presence of F11R-antibodies in patients with thrombocytopenia. Adhesion of platelets through the F11R resulted in events characteristic of the action of cell adhesion molecules (CAMs). To determine the structure of this protein, we cloned the F11R cDNA from human platelets. The predicted amino acid sequence demonstrated that it is an integral membrane protein and an immunoglobulin superfamily member containing 2 extracellular C2-type domains. The structure of the F11R as a member of a CAM family of proteins and its activity in mediating adhesion confirm each another. We conclude that the F11R is a platelet-membrane protein involved in 2 distinct processes initiated on the platelet surface. The first is antibody-induced platelet aggregation and secretion that are dependent on both the FcgammaRII and the GPIIb/IIIa integrin and that may be involved in pathophysiological processes associated with certain thrombocytopenias. The second is an F11R-mediated platelet adhesion that is not dependent on either the FcgammaRII or the fibrinogen receptor and that appears to play a role in physiological processes associated with platelet adhesion and aggregation. (Blood. 2000;95:2600-2609)
- 15 April 2000
- Vol. 95 (8) , 2600-9
Cloning of the human platelet F11 receptor: a cell adhesion molecule member of the immunoglobulin superfamily involved in platelet aggregation.
This study demonstrates that the human platelet F11 receptor (F11R) functions as an adhesion molecule, and this finding is confirmed by the structure of the protein as revealed by molecular cloning. The F11R is a 32-/35-kd protein duplex that serves as the binding site through which a stimulatory monoclonal antibody causes platelet aggregation and granule secretion. A physiological role for the F11R protein was demonstrated by its phosphorylation after the stimulation of platelets by thrombin and collagen. A pathophysiological role for the F11R was revealed by demonstrating the presence of F11R-antibodies in patients with thrombocytopenia. Adhesion of platelets through the F11R resulted in events characteristic of the action of cell adhesion molecules (CAMs). To determine the structure of this protein, we cloned the F11R cDNA from human platelets. The predicted amino acid sequence demonstrated that it is an integral membrane protein and an immunoglobulin superfamily member containing 2 extracellular C2-type domains. The structure of the F11R as a member of a CAM family of proteins and its activity in mediating adhesion confirm each another. We conclude that the F11R is a platelet-membrane protein involved in 2 distinct processes initiated on the platelet surface. The first is antibody-induced platelet aggregation and secretion that are dependent on both the FcgammaRII and the GPIIb/IIIa integrin and that may be involved in pathophysiological processes associated with certain thrombocytopenias. The second is an F11R-mediated platelet adhesion that is not dependent on either the FcgammaRII or the fibrinogen receptor and that appears to play a role in physiological processes associated with platelet adhesion and aggregation. (Blood. 2000;95:2600-2609)
- 1 January 1999
- Published by Elsevier
- Vol. 120, 411-426
Chapter 33 Ecto-protein kinases as mediators for the action of secreted ATP in the brain
- 1 January 1999
- Published by Elsevier
- Vol. 120, 411-426
Chapter 33 Ecto-protein kinases as mediators for the action of secreted ATP in the brain
- 1 January 1998
- Vol. 446, 51-71
Surface protein phosphorylation by ecto-protein kinases. Role in neuronal development and synaptic plasticity.
- 1 January 1998
- Vol. 446, 51-71
Surface protein phosphorylation by ecto-protein kinases. Role in neuronal development and synaptic plasticity.
- 1 November 1996
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 271 (5) , H2134-H2144
Activation of human platelets by protein kinase C antibody: role for surface phosphorylation in homeostasis
A monoclonal antibody that inhibits protein kinase C (PKC) activity, as well as PKC pseudosubstrate inhibitory peptides, was found to cause aggregation of human platelets followed by granular secretion. Binding of this antibody to the platelet surface was demonstrated directly by flow cytometry and immunofluorescence microscopy. Assays of ecto-protein kinase activity revealed that this antibody inhibits the phosphorylation of five proteins on the platelet surface. The platelet aggregation induced by extracellular PKC inhibitors could be blocked by the addition of the membrane-impermeable phosphatase inhibitor, microcystin. Thus the inhibition of surface protein phosphorylation together with continuous dephosphorylation, namely, a decrease in the phosphorylation state of surface proteins, causes the activation of platelets. The aggregation caused by decreased surface phosphorylation appears to be initiated by the exposure of active fibrinogen-binding sites on the platelet surface, as demonstrated by the formation of fibrinogen-dependent microaggregates, as the first step in this process. We conclude that the phosphorylation of surface proteins by a platelet ecto-protein kinase C protects platelets from spontaneous aggregation and thus can play an important role in homeostatic mechanisms that maintain circulating platelets in a resting state.
- 1 November 1996
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 271 (5) , H2134-H2144
Activation of human platelets by protein kinase C antibody: role for surface phosphorylation in homeostasis
A monoclonal antibody that inhibits protein kinase C (PKC) activity, as well as PKC pseudosubstrate inhibitory peptides, was found to cause aggregation of human platelets followed by granular secretion. Binding of this antibody to the platelet surface was demonstrated directly by flow cytometry and immunofluorescence microscopy. Assays of ecto-protein kinase activity revealed that this antibody inhibits the phosphorylation of five proteins on the platelet surface. The platelet aggregation induced by extracellular PKC inhibitors could be blocked by the addition of the membrane-impermeable phosphatase inhibitor, microcystin. Thus the inhibition of surface protein phosphorylation together with continuous dephosphorylation, namely, a decrease in the phosphorylation state of surface proteins, causes the activation of platelets. The aggregation caused by decreased surface phosphorylation appears to be initiated by the exposure of active fibrinogen-binding sites on the platelet surface, as demonstrated by the formation of fibrinogen-dependent microaggregates, as the first step in this process. We conclude that the phosphorylation of surface proteins by a platelet ecto-protein kinase C protects platelets from spontaneous aggregation and thus can play an important role in homeostatic mechanisms that maintain circulating platelets in a resting state.
- 1 January 1993
- Vol. 39 (3) , 257-64
Cyclosporine A enhances agonist-induced aggregation of human platelets by stimulating protein phosphorylation.
Use of the immunosuppressant drug cyclosporine A (CSA) has resulted in improved renal graft survival. However, an increased incidence of arterial and venous thrombotic diseases, hemolytic-uremic type syndrome, and findings resembling vasculitis in the kidneys of patients with CSA nephrotoxicity and accelerated atherogenesis have been reported. These disorders may be related to CSA-induced abnormalities in platelet function. We report here that CSA causes increased ADP-stimulated aggregation in isolated platelet suspensions indicating that CSA has a direct effect on platelet function, independent of CSA interactions with plasma factors. Maximal hyperaggregability of ADP-stimulated platelets occurred following a 1 h preincubation period with CSA. Hyperaggregability of platelets due to the presence of CSA was dose-dependent and approached plateau between 200-500 ng/ml CSA. We determined that CSA exerted its effects through a signal transduction pathway involving the phosphorylation of two intracellular proteins, a 40 kD substrate of PKC (p47) and the 20 kD light chain of myosin (p20), a substrate of calcium/calmodulin dependent kinase. Preincubation with CSA resulted in a 200% increase in the phosphorylation of these proteins in platelets stimulated with ADP. We conclude that CSA enhances ADP-induced platelet aggregation and secretion, in part, by potentiating the phosphorylative response of specific intracellular proteins to stimulation by agonists. This process may be responsible for the increased thrombosis and atherogenesis observed in CSA-treated patients.
- 1 January 1993
- Vol. 39 (3) , 257-64
Cyclosporine A enhances agonist-induced aggregation of human platelets by stimulating protein phosphorylation.
Use of the immunosuppressant drug cyclosporine A (CSA) has resulted in improved renal graft survival. However, an increased incidence of arterial and venous thrombotic diseases, hemolytic-uremic type syndrome, and findings resembling vasculitis in the kidneys of patients with CSA nephrotoxicity and accelerated atherogenesis have been reported. These disorders may be related to CSA-induced abnormalities in platelet function. We report here that CSA causes increased ADP-stimulated aggregation in isolated platelet suspensions indicating that CSA has a direct effect on platelet function, independent of CSA interactions with plasma factors. Maximal hyperaggregability of ADP-stimulated platelets occurred following a 1 h preincubation period with CSA. Hyperaggregability of platelets due to the presence of CSA was dose-dependent and approached plateau between 200-500 ng/ml CSA. We determined that CSA exerted its effects through a signal transduction pathway involving the phosphorylation of two intracellular proteins, a 40 kD substrate of PKC (p47) and the 20 kD light chain of myosin (p20), a substrate of calcium/calmodulin dependent kinase. Preincubation with CSA resulted in a 200% increase in the phosphorylation of these proteins in platelets stimulated with ADP. We conclude that CSA enhances ADP-induced platelet aggregation and secretion, in part, by potentiating the phosphorylative response of specific intracellular proteins to stimulation by agonists. This process may be responsible for the increased thrombosis and atherogenesis observed in CSA-treated patients.
- 1 January 1987
- Vol. 249, 193-204
Extracellular protein phosphorylation systems in the regulation of cellular responsiveness.
In cells which store ATP within secretory vesicles and release it by exocytosis upon cell stimulation, extracellular protein phosphorylation systems may play an important role in cellular activation and intercellular communication. Secretion of ATP has been well documented in three cell types: neurons, chromaffin cells of the adrenal medulla and platelets. In each of these cell types we have found extracellular protein phosphorylation systems and surface proteins phosphorylated by extracellular ATP. Two types of extracellular protein kinases have been detected: a membrane bound ecto-protein kinase and a soluble, secreted exo-protein kinase. The ecto-protein kinase has properties consistent with involvement in the feedback regulation of cellular activation. The secreted protein kinase can phosphorylate proteins of the extracellular matrix and surface proteins of target cells, and thus may serve as an enzyme with the role of first messenger in cell-cell communication.
- 1 January 1987
- Vol. 249, 193-204
Extracellular protein phosphorylation systems in the regulation of cellular responsiveness.
In cells which store ATP within secretory vesicles and release it by exocytosis upon cell stimulation, extracellular protein phosphorylation systems may play an important role in cellular activation and intercellular communication. Secretion of ATP has been well documented in three cell types: neurons, chromaffin cells of the adrenal medulla and platelets. In each of these cell types we have found extracellular protein phosphorylation systems and surface proteins phosphorylated by extracellular ATP. Two types of extracellular protein kinases have been detected: a membrane bound ecto-protein kinase and a soluble, secreted exo-protein kinase. The ecto-protein kinase has properties consistent with involvement in the feedback regulation of cellular activation. The secreted protein kinase can phosphorylate proteins of the extracellular matrix and surface proteins of target cells, and thus may serve as an enzyme with the role of first messenger in cell-cell communication.